Backfluorinated nhc carbenes and complexes
US-2015004322-A1 · Jan 1, 2015 · US
US10150738B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10150738-B2 |
| Application number | US-201715596780-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 16, 2017 |
| Priority date | Oct 9, 2014 |
| Publication date | Dec 11, 2018 |
| Grant date | Dec 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion; the method comprises cyclization of a halogenated acrylate with Hünig's base in a solvent.
Opening claim text (preview).
What is claimed is: 1. A method of synthesizing a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion, the method comprising: providing a halogenated acrylate or maleate having R 1 and R 2 groups; and cyclization of the halogenated acrylate with a primary base in a solvent and a formamidine complex having R 3 and R 4 groups, the primary base being Hünig's base. 2. The method of claim 1 , wherein the solvent is acetone or toluene. 3. The method of claim 1 , further comprising: introducing a secondary base during the cyclization. 4. The method of claim 3 , wherein the secondary base is triethylamine. 5. The method of claim 1 , wherein each of R 3 and R 4 is separately selected from the group consisting of a C1-C20 alkyl group, C1-C20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C1-C20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C1-C20 partially fluorinated aliphatic group, and a C1-C20 aryl group. 6. The method of claim 1 , wherein X is a halogen anion. 7. The method of claim 1 , wherein the R 1 group is in a trans-configuration with respect to the R 2 group. 8. The method of claim 1 , wherein the solvent is a polar aprotic solvent. 9. The method of claim 8 , wherein the polar aprotic solvent is selected from the group consisting of ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, and triethylene glycol dimethyl ether. 10. A method of synthesizing a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion, the method comprising: providing a halogenated acrylate or maleate having R 1 and R 2 groups; and formamidine cyclization of a halogenated, fluorinated allyl ether with Hünig's base in polar aprotic solvent, the formamidine having R 3 and R 4 groups. 11. The method of claim 10 , further comprising: introducing a secondary base during the cyclization. 12. The method of claim 11 , wherein the secondary base is triethylamine. 13. The method of claim 10 , wherein each of R 3 and R 4 is separately selected from the group consisting of a C1-C20 alkyl group, C1-C20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C1-C20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C1-C20 partially fluorinated aliphatic group, and a C1-C20 aryl group. 14. The method of claim 10 , wherein the R 1 group is in a trans-configuration with respect to the R 2 group. 15. The method of claim 10 , wherein the polar aprotic solvent is selected from the group consisting of ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, and triethylene glycol dimethyl ether.
Iridium compounds · CPC title
Ruthenium compounds · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.